Medical Care Technologies Inc. (OTC Pink:MDCE) Previews MDCE Melanoma Scan Beta on Corporate Website
Medical Care Technologies Inc. (OTC Pink:MDCE) Previews MDCE Melanoma Scan Beta on Corporate Website
Publish Date: 2026-05-22 08:30:00
Source Domain: www.newswire.com
-
Public Beta Launch: Medical Care Technologies Inc. has announced the public beta preview of MDCE Melanoma Scan, a healthcare-focused artificial intelligence application intended for visual analysis in preventive health awareness.
-
AI Expansion Strategy: The beta preview signifies the company’s ongoing growth in AI strategy encompassing various sectors including consumer, wellness, enterprise, and medical technology.
-
AI Roadmap: The beta addition aligns with the company’s expanding AI roadmap, which also involves recently launched consumer AI initiatives and other initiatives in development.
-
Executive Statement: Marshall Perkins III, the CEO of MDCE, emphasized the company’s commitment to creating scalable AI opportunities across multiple high-growth sectors.
-
Revenue-Supporting Subsidiaries: The company leverages its subsidiaries, Infinite Auctions and Real Game Used, to generate revenue and support its broader growth strategy.
-
Cautionary Note on MDCE Melanoma Scan: The product is still in beta-stage development and lacks regulatory clearance; it is not designed to diagnose, treat, cure, or prevent any disease nor should it replace professional medical evaluation.
-
Forward-Looking Statements: The press release contains forward-looking statements regarding future product development, commercialization, and strategic expansion, accompanied by certain risks and uncertainties inherent to such future projections.
-
Company Overview: Medical Care Technologies Inc. is a diversified technology firm devoted to AI-powered applications in healthcare, wellness, nutrition, lifestyle, and enterprise imaging analysis.
